What the Top Ten epilepsy research priorities mean for the UK research ecosystem.

Journal Information

Full Title: EBioMedicine

Abbreviation: EBioMedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of interests Rhys H Thomas has received honoraria from Angelini/Arvelle, Bial, Biocodex, Eisai, Jazz/GW Pharma, NeuraxPharm, Sanofi, Takeda, UCB Pharma, UNEEG, Zogenix, and unrestricted research funding from Angelini/Arvelle and UNEEG. The UK Epilepsy Priority Setting Partnership (PSP) was funded, led and managed by the Epilepsy Research Institute UK (formerly Epilepsy Research UK). The Epilepsy Research Institute UK is a company registered in England and Wales with company number 4873718. Registered office: Churchill House, 35 Red Lion Square, London, WC1R 4SG."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025